VACCINES

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

Adjuvant Composition Comprising STING Agonists

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

VARICELLA-ZOSTER VIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES

HERPES ZOSTER mRNA VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF

EXTRACELLULAR VESICLE COMPRISING ANTIGENIC PROTEIN OR GENE ENCODING SAME PROTEIN, AND USES THEREOF

VACCINE COMPOSITION OR KIT FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE, CONTAINING GENETIC MATERIAL THAT ENCODES FOREIGN ANTIGEN

MODIFIED VARICELLA ZOSTER VIRUS GLYCOPROTEIN E PROTEINS

VACCINE ADJUVANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

METHODS AND COMPOSITIONS RELATING TO IMMUNIZATION OF IMMUNE DISTINCT PATIENTS

SIGNAL SEQUENCES FOR NUCLEIC ACID VACCINES

VARICELLA ZOSTER VIRUS (VZV) VACCINE

ADJUVANT COMPOUNDS AND FORMULATIONS

RNA FORMULATIONS AND LIPIDS

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF VIRAL ANTIGENS AND RELATED METHODS

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

IDENTIFYING PATIENT POPULATIONS VULNERABLE TO VIRAL INFECTION AND METHODS OF INDUCING HETEROLOGOUS IMMUNITY IN SAME

ENGINEERED VARICELLA ZOSTER VIRUS SHINGLES MRNA VACCINE

VACCINE COMPOSITION FOR CHICKENPOX OR VARICELLA ZOSTER AND METHOD OF USING SAME

ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF

REPLICATION-DEFECTIVE VACCINES AND USES THEREOF

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

Saponin purification

VACCINES, VACCINE PRIMING, AND ANTIGEN DOSE SPARING

RNA MOLECULES

POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTS

VARICELLA ZOSTER VIRUS VACCINE

VARICELLA ZOSTER VIRUS FUSION PROTEIN AND IMMUNOGENIC COMPOSITION COMPRISING SAME

NON-NEUROINVASIVE VIRUSES AND USES THEREOF

SHINGLES VACCINES COMPRISING A TLR9 AGONIST

DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE

VARICELLA ZOSTER

Varicella zoster virus (VZV) vaccine

Recombinant varicella-zoster virus (VZV) vaccine

Recombinant Herpes Zoster Vaccine Composition and Application Thereof

T CELL EPITOPES OF HCMV AND USES OF THEREOF

PREPARATION OF ZINC RISEDRONATE MICRO/NANO ADJUVANT AND USE THEREOF AS VACCINE ADJUVANT

PREPARATION OF ZINC ZOLEDRONATE MICRO-NANOPARTICLE ADJUVANT AND USE THEREOF AS VACCINE ADJUVANT

Recombinant virus with diminished latency and methods of using same

SAMRNA VACCINE AND PREPARATION METHOD THEREFOR

Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy

Identifying patient populations vulnerable to viral infection and methods of inducing heterologous immunity in same

COMPOSITIONS AND METHODS

Modified CMV gB protein and CMV vaccine including same

Dosage Regimen for the Treatment of Multiple Sclerosis with a S1P Receptor Modulator

IMMUNE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Dosage regimen of an S1P receptor modulator

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

Antigen variant of Varicella Zoster virus and use thereof

VACCINATION

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

VARICELLA ZOSTER VIRUS VACCINE

Broadly neutralizing anti-human cytomegalovirus (HCMV) antibodies and methods of use thereof

Saponin purification

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Non-neuroinvasive viruses and uses thereof

Non-neuroinvasive viruses and uses thereof

Vaccine adjuvant comprising lipopeptide-inserted liposome as effective ingredient and use thereof

Varicella zoster virus (VZV) vaccine

Vaccine compositions of herpesvirus envelope protein combinations to induce immune response

Varicella zoster virus vaccine

Herpes zoster vaccine composition

Specific binding agents to varicella-zoster virus and uses related thereto

Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same

Recombinant virus with diminished latency and methods of using same

Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof

Method to increase the infectivity of virus particles

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

DNA VACCINE COMPOSITION FOR PREVENTING AND TREATING HERPES ZOSTER, AND METHOD FOR ACTIVATING T CELLS FOR VZV ANTIGEN BY USING SAME

Non-neuroinvasive viruses and uses thereof

VACCINATION

Cytomegalovirus antigens and uses thereof

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

Methods of selecting T cell line and donor thereof for adoptive cellular therapy

Adjuvant for mucosal vaccine

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

Nasal mucosal vaccine composition

Mucosal vaccine composition

Methods of immunization with varicella zoster virus antigen

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

Conditionally replication deficient herpes virus and use thereof in vaccines

VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

Method to increase the infectivity of virus particles

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Vaccine for inducing an improved immune reaction

Recombinant virus with diminished latency and methods of using same

RECOMBINANT VARICELLA-ZOSTER VIRUS

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

Recombinant Varicella-Zoster Virus

Vaccine against varicella zoster virus

VACCINE AGAINST VARICELLA ZOSTER VIRUS

RECOMBINANT MULTIVALENT VACCINE

USE OF A VARICELLOVIRUS TAP-INHIBITOR FOR THE INDUCTION OF TUMOR-OR VIRUS-SPECIFIC IMMUNITY AGAINST TEIPP

Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

Recombinant Vaccine from gE, gI, and gB Proteins of the Varicella-Zoster Virus for the Treatment and Prevention of Multiple Sclerosis

Vaccine

Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity

VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES

Recombinant vaccine from gE, gI, and gB proteins of the varicella-zoster virus for the treatment and prevention of multiple sclerosis

Genetically engineered cell lines and systems for propagating virus and methods of use thereof

Herpes zoster mRNA vaccine, preparation method therefor, and use thereof

Nucleic acid vaccines for varicella zoster virus (VZV)